The implications of US healthcare price transparency
McKinsey April 2, 2024
Price transparency is one of several industry innovations that is increasing the potential for consumerism in US healthcare.
It has been more than a year and a half and three years, respectively, since federal price transparency rules went into effect for payers and hospitals. Together, the two rules require public disclosure of all commercial payer–provider negotiated rates, and they include other provisions aimed at improving price transparency.
After a slow start, payers and hospitals have made progress toward publishing negotiated rates. In the meantime, regulators are continuing to take actions to further advance price transparency. For example, the Centers for Medicare & Medicaid Services (CMS) has shortened the time hospitals have to respond to notices of noncompliance and has imposed...